(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DOT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DOT

ST13

US500000079350921

Class

1, 3, 5, 10

Filing

79350921

Registration

7292352

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/21/2024

Trademark type

Word

Nice classes

1, 3, 5, 10

Filing date

08/19/2022

Registration date

01/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/30/2024

Last transaction

01/30/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

MASON,JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Pharmaresearch Co., Ltd.

Representatives

Sangwon Kim Revolution IP, PLLC

Technical classification

Nice Classes

Class 1Class 3Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Industrial chemicals; chemical preparations for use in industry; reagents for scientific or medical research use; Chemicals in the nature of nucleic acid for scientific purposeother than for medical or veterinary use; nucleic acid for scientific or laboratory purposes; biochemical precursors for scientific purposes; Biochemical precursors for scientific purposes in particular precursors for in vitro genetic engineering use; Antibodies for scientific purposesother than for medical or veterinary use in particular monoclonal antibodies for in vitro scientific or research use; Nucleic acids for scientific laboratory purposes; chemical preparations for scientific purposesother than for medical or veterinary use; chemical preservatives for use in the production of a wide variety of chemicals; Protein for industrial use; saltraw for industrial use; adjuvantsother than for medical or veterinary purposes; proteins for use in the manufacture of food supplements; vitamins for use in the manufacture of food supplements; antioxidants for use in the manufacture of food supplements; Chemical catalysts for oxidation processesnot of metal; Biological preparations for use in scienceother than for medical or veterinary purposes; biochemicals for in vitro and in vivo scientific use; Chemical additives for food manufacture; amino acid for food industry; proteins for the food industry; vitamins for the food industry; enzymes for the food industry; vitamins for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; phosphorus; phosphoric acid; phosphatides; Glycerin for use in the manufacture of pharmaceuticals; proteins for use in manufacture Lipids for use in the manufacture of food supplements; vitamins for use in the manufacture of cosmetics; oligopeptides for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; plant extractsother than essential oilsfor use in the manufacture of cosmetics; tea extracts for use in the manufacture of cosmetics; chemical additives for use in the manufacture of cosmetics; collagen for use as a raw ingredient in the manufacture of cosmetics

Class 3

Air fragrance reed diffusers

Class 5

Pharmaceutical preparations for the prevention of osteoporosis; non-prescription medicines in the nature of pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vitamin supplements; pharmaceutical preparations for wounds; Crude pharmaceutical preparations for use in the treatment of damaged skin and tissue; bone void fillers comprised of living tissues; anti-inflammatories; steroids; ophthalmologic preparations; Chemico-pharmaceutical preparations for use in the treatment of damaged skin and tissue; processed human donor skin for the replacement of soft tissue; surgical implants comprised of living tissues; Chemical preparations for medical or veterinary purposes in particular for use in the treatment of damaged skin and tissue; Biochemical preparations for medical or veterinary purposes in particular for use in the treatment of damaged skin and tissue; medicated lotions and creams for the bodyskinfacehands; Biotechnological preparations for medical purposes in particular for use in the treatment of damaged skin and tissue; Biological preparations for medical purposes in particular for use in the treatment of damaged skin and tissue; medicated shampoos; medicated toiletry preparations; medicinal creams for skin care; amino acid preparations for medical purposes; pre-filled syringes filled with pharmaceutical preparations for the treatment of damaged skin and tissue for medical purposes; medicated creams for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated ointments for treating dermatological conditions; Synthetic peptides for pharmaceutical purposes in particular for use in the treatment of damaged skin and tissue; pharmaceuticals preparations for use in the treatment of damaged skin and tissue; Biological skin tissue intended for subsequent implantation; Medicines for human purposespharmaceutical preparation for skin care; Medicines for dental purposesmedicated dental rinses; Nutraceutical preparations for use as a dietary supplement; pharmaceutical preparations for skin care; preparations for the treatment of burns; chemotherapeutics

Class 10

Implants consisting of artificial materials for use in bone grafting; Joint pain therapy apparatusorthopedic device for injecting drugs into joint spaces; Machines and apparatus for hair grown functional scalp treatmentslasers for the cosmetic treatment of hair follicles and scalp; medical apparatus for introducing pharmaceutical preparations into the human body; apparatus for acne treatment; surgical apparatus and instruments; bone substitutes for surgical use; artificial skin for surgical purposes; surgical apparatus and instruments for medicaldental or veterinary use; syringes for medical purposes; massage apparatus for medical purposes; needles for medical purposes; disposable hypodermic syringes for medical use; body rehabilitation apparatus for medical purposes; medical surgical instruments for use in dermatoplasty; Medical apparatus for injecting fillers being syringes for medical purposes; surgical implants comprised of artificial materials; endoprostheses; implants consisting of artificial materials; osseous implants made of artificial materials; Electrical nerve stimulators for medical purposes; Orthopedic joint implants made of artificial materials; laser therapy helmets for treating alopecia; Skin regeneration therapy apparatusapparatus for the regeneration of stem cells for medical purposes; hypodermic syringes

Publications

History of USPTO decisions and trademark events.

29 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/21/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/30/2024

FIMP

FINAL DISPOSITION PROCESSED

04/30/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/30/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/14/2023

PUBO

PUBLISHED FOR OPPOSITION

11/14/2023

GPNX

NOTIFICATION PROCESSED BY IB

11/13/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/25/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/25/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/25/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/12/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

10/12/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/12/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

10/12/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/10/2023

RFNT

REFUSAL PROCESSED BY IB

08/07/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/20/2023

RFRR

REFUSAL PROCESSED BY MPU

07/20/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/15/2023

CNRT

NON-FINAL ACTION WRITTEN

06/14/2023

DOCK

ASSIGNED TO EXAMINER

06/07/2023

MAFR

APPLICATION FILING RECEIPT MAILED

10/04/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/29/2022

Continuous trademark protection

Get notified about every new filing that threatens DOT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.